Literature DB >> 34185552

Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35611 Participants.

Pedro C Hallal1, Mariangela F Silveira1, Ana M B Menezes1, Bernardo L Horta1, Aluísio J D Barros1, Lucia C Pellanda1, Gabriel D Victora1, Odir A Dellagostin1, Claudio J Struchiner1, Marcelo N Burattini1, Marilia A Mesenburg1, Nadege Jacques1, Luís Paulo Vidaletti1, Emanuele L Ambros1, Evelise M Berlezi1, Helena Schirmer1, Jane D P Renner1, Kaue Collares1, Maria Letícia R Ikeda1, Thiago M Ardenghi1, Patricia de Gasperi1, Fernando P Hartwig1, Fernando C Barros1, Cesar G Victora1.   

Abstract

Objectives. To evaluate the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over 6 months in the Brazilian State of Rio Grande do Sul (population 11.3 million), based on 8 serological surveys. Methods. In each survey, 4151 participants in round 1 and 4460 participants in round 2 were randomly sampled from all state regions. We assessed presence of antibodies against SARS-CoV-2 using a validated lateral flow point-of-care test; we adjusted figures for the time-dependent decay of antibodies. Results. The SARS-CoV-2 antibody prevalence increased from 0.03% (95% confidence interval [CI] = 0.00%, 0.34%; 1 in every 3333 individuals) in mid-April to 1.89% (95% CI = 1.36%, 2.54%; 1 in every 53 individuals) in early September. Prevalence was similar across gender and skin color categories. Older adults were less likely to be infected than younger participants. The proportion of the population who reported leaving home daily increased from 21.4% (95% CI = 20.2%, 22.7%) to 33.2% (95% CI = 31.8%, 34.5%). Conclusions. SARS-CoV-2 infection increased slowly during the first 6 months in the state, differently from what was observed in other Brazilian regions. Future survey rounds will continue to document the spread of the pandemic. (Am J Public Health. Published online ahead of print June 29, 2021: e1-e9. https://doi.org/10.2105/AJPH.2021.306351).

Entities:  

Year:  2021        PMID: 34185552     DOI: 10.2105/AJPH.2021.306351

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  2 in total

1.  A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey.

Authors:  Valerio Marra; Miguel Quartin
Journal:  Int J Infect Dis       Date:  2021-08-12       Impact factor: 3.623

2.  Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality.

Authors:  Prof Cesar Victora; Prof Marcia C Castro; Susie Gurzenda; Arnaldo C Medeiros; Giovanny V A França; Prof Aluisio J D Barros
Journal:  EClinicalMedicine       Date:  2021-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.